NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637953.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 800 | +14.3% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 700 | -98.2% | 0.00% | – |
| Q4 2021 | $22,000 | +37.5% | 38,300 | +204.0% | 0.00% | – |
| Q3 2021 | $16,000 | 0.0% | 12,600 | +2.4% | 0.00% | – |
| Q2 2021 | $16,000 | -76.5% | 12,300 | +2835.6% | 0.00% | – |
| Q1 2021 | $68,000 | -6.8% | 419 | +36.5% | 0.00% | – |
| Q4 2020 | $73,000 | – | 307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 790 | $94,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 16,400 | $20,000 | 0.00% |
| SIMPLEX TRADING, LLC | 12,600 | $16,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |